Publikationen, an denen er mitarbeitet TOMAS M. M. GARCIA-CABALLERO PARADA (1)

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13